Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Evaluation of the Clinical Performance and Safety of Apneal Dx for the Screening and Aid in the Diagnosis of Obstructive Sleep Apnea-hypopnea Syndrome in Adults: a Post-market Clinical Follow-up Study

NCT07809633 is registered in ClinicalTrials.gov with Mitral as lead sponsor.

NCT NCT07809633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07809633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Evaluation of the Clinical Performance and Safety of Apneal Dx for the Screening and Aid in the Diagnosis of Obstructive Sleep Apnea-hypopnea Syndrome in Adults: a Post-market Clinical Follow-up Study
Lead sponsor
Mitral
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
June 30, 2031
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea, sleep apnea syndromes, sleep apnea, obstructive